Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
In a real-world population of adults with migraine, the investigators would like to investigate whether 12.5 mg almotriptan is non-inferior to 50 mg ubrogepant in terms of pain freedom at 2 hours after drug intake.
提供机构：
ClinicalTrials.gov
